Analysis of chemical and biological features yields mechanistic insights into drug side effects

Chemistry and Biology

Volumn 20, Issue 4, 2013, Pages 594-603

  Duran Frigola, Miquel ^a   Aloy, Patrick ^a,b  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL COMPOUND; ENZYME INHIBITOR; INTERSTITIAL COLLAGENASE; PIPERAZINE;

AORTA VALVE DISEASE; ARTICLE; CALCINOSIS; CHEMISTRY; DATA BASE; DRUG INFORMATION; DRUG MECHANISM; EAR DISEASE; ENDOCRINE DISEASE; FALSE POSITIVE RESULT; FISHER EXACT TEST; HEART DISEASE; HEMATOLOGIC DISEASE; HEPATOBILIARY DISEASE; HUMAN; INNER EAR DISEASE; LYMPHATIC SYSTEM DISEASE; METABOLITE; METHODOLOGY; MOLECULAR BIOLOGY; PRIORITY JOURNAL; SIDE EFFECT;

ALGORITHMS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; PHARMACEUTICAL PREPARATIONS; PHENOTYPE; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEINS;

EID: 84876496265     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2013.03.017     Document Type: Article

References (54)

1. A. Alexa, J. Rahnenfuhrer, and T. Lengauer Improved scoring of functional groups from gene expression data by decorrelating GO graph structure Bioinformatics 22 2006 1600 1607
2. W.N. Arnold, and L.S. Loftus Xanthopsia and van Gogh's yellow palette Eye (Lond.) 5 1991 503 510
3. A. Bauer-Mehren, E.M. van Mullingen, P. Avillach, C. Carrascosa Mdel, R. Garcia-Serna, J. Pinero, B. Singh, P. Lopes, J.L. Oliveira, and G. Diallo Automatic filtering and substantiation of drug safety signals PLoS Comput. Biol. 8 2012 e1002457
4. L. Becquemont Pharmacogenomics of adverse drug reactions: practical applications and perspectives Pharmacogenomics 10 2009 961 969
5. G.W. Bemis, and M.A. Murcko The properties of known drugs. 1. Molecular frameworks J. Med. Chem. 39 1996 2887 2893
6. A. Bender, J. Scheiber, M. Glick, J.W. Davies, K. Azzaoui, J. Hamon, L. Urban, S. Whitebread, and J.L. Jenkins Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure ChemMedChem 2 2007 861 873
7. S.I. Berger, and R. Iyengar Role of systems pharmacology in understanding drug adverse events Wiley Interdiscip. Rev. Syst. Biol. Med. 3 2011 129 135
8. P.J. Blanchet, M.T. Parent, P.H. Rompre, and D. Levesque Relevance of animal models to human tardive dyskinesia Behav. Brain Funct. 8 2012 12
9. A. Cami, A. Arnold, S. Manzi, and B. Reis Predicting adverse drug events using pharmacological network models Sci. Transl. Med. 3 2011 114ra127
10. M. Campillos, M. Kuhn, A.C. Gavin, L.J. Jensen, and P. Bork Drug target identification using side-effect similarity Science 321 2008 263 266
11. J. Clayton-Smith, S. Walters, E. Hobson, E. Burkitt-Wright, R. Smith, A. Toutain, J. Amiel, S. Lyonnet, S. Mansour, and D. Fitzpatrick Xq28 duplication presenting with intestinal and bladder dysfunction and a distinctive facial appearance Eur. J. Hum. Genet. 17 2009 434 443
12. A.P. Davis, C.G. Murphy, R. Johnson, J.M. Lay, K. Lennon-Hopkins, C. Saraceni-Richards, D. Sciaky, B.L. King, M.C. Rosenstein, and T.C. Wiegers The Comparative Toxicogenomics Database: update 2013 Nucleic Acids Res. 41 2013 D1104 D1114
13. P. de Matos, R. Alcantara, A. Dekker, M. Ennis, J. Hastings, K. Haug, I. Spiteri, S. Turner, and C. Steinbeck Chemical entities of biological interest: an update Nucleic Acids Res. 38 2010 D249 D254
14. J.D. Ferreira, and F.M. Couto Semantic similarity for automatic classification of chemical compounds PLoS Comput. Biol. 6 2010 pii: e1000937
15. A. Fura Role of pharmacologically active metabolites in drug discovery and development Drug Discov. Today 11 2006 133 142
16. R. Garcia-Serna, O. Ursu, T.I. Oprea, and J. Mestres iPHACE: integrative navigation in pharmacological space Bioinformatics 26 2010 985 986
17. R.C. Gentleman, V.J. Carey, D.M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, and J. Gentry Bioconductor: open software development for computational biology and bioinformatics Genome Biol. 5 2004 R80
18. K.M. Giacomini, R.M. Krauss, D.M. Roden, M. Eichelbaum, M.R. Hayden, and Y. Nakamura When good drugs go bad Nature 446 2007 975 977
19. A. Gottlieb, G.Y. Stein, E. Ruppin, and R. Sharan PREDICT: a method for inferring novel drug indications with application to personalized medicine Mol. Syst. Biol. 7 2011 496
20. D. Gurwitz, and A.G. Motulsky 'Drug reactions, enzymes, and biochemical genetics': 50 years later Pharmacogenomics 8 2007 1479 1484
21. M.E. Hillenmeyer, E. Ericson, R.W. Davis, C. Nislow, D. Koller, and G. Giaever Systematic analysis of genome-wide fitness data in yeast reveals novel gene function and drug action Genome Biol. 11 2010 R30
22. P. Holzer Opioid receptors in the gastrointestinal tract Regul. Pept. 155 2009 11 17
23. M. Kanehisa, and S. Goto KEGG: kyoto encyclopedia of genes and genomes Nucleic Acids Res. 28 2000 27 30
24. M.J. Keiser, B.L. Roth, B.N. Armbruster, P. Ernsberger, J.J. Irwin, and B.K. Shoichet Relating protein pharmacology by ligand chemistry Nat. Biotechnol. 25 2007 197 206
25. M.J. Keiser, V. Setola, J.J. Irwin, C. Laggner, A.I. Abbas, S.J. Hufeisen, N.H. Jensen, M.B. Kuijer, R.C. Matos, and T.B. Tran Predicting new molecular targets for known drugs Nature 462 2009 175 181
26. C. Knox, V. Law, T. Jewison, P. Liu, S. Ly, A. Frolkis, A. Pon, K. Banco, C. Mak, and V. Neveu DrugBank 3.0: a comprehensive resource for 'omics' research on drugs Nucleic Acids Res. 39 2011 D1035 D1041
27. M. Kuhn, M. Campillos, I. Letunic, L.J. Jensen, and P. Bork A side effect resource to capture phenotypic effects of drugs Mol. Syst. Biol. 6 2010 343
28. M. Kuhn, D. Szklarczyk, A. Franceschini, C. von Mering, L.J. Jensen, and P. Bork STITCH 3: zooming in on protein-chemical interactions Nucleic Acids Res. 40 2012 D876 D880
29. S. Lee, K.H. Lee, M. Song, and D. Lee Building the process-drug-side effect network to discover the relationship between biological processes and side effects BMC Bioinformatics 12 Suppl 2 2011 S2
30. R. Lin, K. Karpa, N. Kabbani, P. Goldman-Rakic, and R. Levenson Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A Proc. Natl. Acad. Sci. USA 98 2001 5258 5263
31. E. Lounkine, M.J. Keiser, S. Whitebread, D. Mikhailov, J. Hamon, J.L. Jenkins, P. Lavan, E. Weber, A.K. Doak, and S. Cote Large-scale prediction and testing of drug activity on side-effect targets Nature 486 2012 361 367
32. G.A. McQuibban, J.H. Gong, J.P. Wong, J.L. Wallace, I. Clark-Lewis, and C.M. Overall Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo Blood 100 2002 1160 1167
33. J. Mestres, L. Martin-Couce, E. Gregori-Puigjane, M. Cases, and S. Boyer Ligand-based approach to in silico pharmacology: nuclear receptor profiling J. Chem. Inf. Model. 46 2006 2725 2736
34. J. Mestres, E. Gregori-Puigjane, S. Valverde, and R.V. Sole Data completeness - the Achilles heel of drug-target networks Nat. Biotechnol. 26 2008 983 984
35. N.M. O'Boyle, M. Banck, C.A. James, C. Morley, T. Vandermeersch, and G.R. Hutchison Open Babel: an open chemical toolbox J. Cheminform. 3 2011 33
36. T.I. Oprea, and J. Gottfries Chemography: the art of navigating in chemical space J. Comb. Chem. 3 2001 157 166
37. E. Pauwels, V. Stoven, and Y. Yamanishi Predicting drug side-effect profiles: a chemical fragment-based approach BMC Bioinformatics 12 2011 169
38. F. Pedregosa, G. Varoquaux, A. Gramfort, V. Michel, B. Thirion, O. Grisel, M. Blondel, P. Prettenhofer, R. Weiss, and V. Dubourg Scikit-learn: machine learning in Python J. Mach. Learn. Res. 12 2011 2825 2830
39. C. Pesquita, D. Faria, A.O. Falcao, P. Lord, and F.M. Couto Semantic similarity in biomedical ontologies PLoS Comput. Biol. 5 2009 e1000443
40. J. Scheiber, J.L. Jenkins, S.C. Sukuru, A. Bender, D. Mikhailov, M. Milik, K. Azzaoui, S. Whitebread, J. Hamon, and L. Urban Mapping adverse drug reactions in chemical space J. Med. Chem. 52 2009 3103 3107
41. N. Senanayake, and G.C. Roman Disorders of neuromuscular transmission due to natural environmental toxins J. Neurol. Sci. 107 1992 1 13
42. M. Shuvy, S. Abedat, R. Beeri, M. Valitsky, S. Daher, M. Kott-Gutkowski, A. Gal-Moscovici, J. Sosna, N.M. Rajamannan, and C. Lotan Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure Am. J. Physiol. Heart Circ. Physiol. 300 2011 H1829 H1840
43. M. Soler-López, A. Zanzoni, R. Lluis, U. Stelzl, and P. Aloy Interactome mapping suggests new mechanistic details underlying Alzheimer's disease Genome Res. 21 2011 364 376
44. N.P. Tatonetti, P.P. Ye, R. Daneshjou, and R.B. Altman Data-driven prediction of drug effects and interactions Sci. Transl. Med. 4 2012 125ra131
45. A. Trifilieff, A. Da Silva, and J.P. Gies Kinins and respiratory tract diseases Eur. Respir. J. 6 1993 576 587
46. B.M. Tune, and D. Fravert Mechanisms of cephalosporin nephrotoxicity: a comparison of cephaloridine and cephaloglycin Kidney Int. 18 1980 591 600
47. R. Vallon, R. Muller, D. Moosmayer, E. Gerlach, and P. Angel The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1) Eur. J. Biochem. 244 1997 81 88
48. T. Varin, A. Schuffenhauer, P. Ertl, and S. Renner Mining for bioactive scaffolds with scaffold networks: improved compound set enrichment from primary screening data J. Chem. Inf. Model. 51 2011 1528 1538
49. L.M. Vasquez-Pinto, F. Nantel, P. Sirois, and S. Jancar Bradykinin B(1) receptor antagonist R954 inhibits eosinophil activation/proliferation/migration and increases TGF-beta and VEGF in a murine model of asthma Neuropeptides 44 2010 107 113
50. A. Vedani, M. Dobler, and M. Smiesko VirtualToxLab - a platform for estimating the toxic potential of drugs, chemicals and natural products Toxicol. Appl. Pharmacol. 261 2012 142 153
51. I. Wallach, N. Jaitly, and R. Lilien A structure-based approach for mapping adverse drug reactions to the perturbation of underlying biological pathways PLoS ONE 5 2010 e12063
52. S. Wetzel, K. Klein, S. Renner, D. Rauh, T.I. Oprea, P. Mutzel, and H. Waldmann Interactive exploration of chemical space with Scaffold Hunter Nat. Chem. Biol. 5 2009 581 583
53. D.P. Williams, and B.K. Park Idiosyncratic toxicity: the role of toxicophores and bioactivation Drug Discov. Today 8 2003 1044 1050
54. T.Y. Wu, M.H. Jen, A. Bottle, M. Molokhia, P. Aylin, D. Bell, and A. Majeed Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009 J. R. Soc. Med. 103 2010 239 250